超媒體控(00072.HK)預計年度淨利潤不低於100萬元 同比扭虧
格隆匯3月29日丨超媒體控(00072.HK)公佈,集團預計與截至2020年12月31日止年度淨虧損約人民幣7000萬元相比,截至2020年12月31日止年度將錄得淨利潤不低於人民幣100萬元。
董事會認為集團轉虧為盈,主要由於2021年,儘管COVID-19疫情於中國大陸及香港的爆發對集團的業務及運營造成不利影響,但由於集團不斷創新及擴展業務模式,集團各業務線的業績有所改善。為積極應對疫情帶來的持續不利影響,自2020年下半年以來,集團採取加強預算管理及優化組織結構等一系列成本控制措施。此外,集團的藝術平台及數碼平台實現發展及創新,於完善相關流程及細化成本控制方面亦取得突破。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.